Wealth Enhancement Advisory Services’s Vaxart VXRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,400
Closed -$3.65K 3813
2025
Q3
$3.65K Hold
10,400
﹤0.01% 3576
2025
Q2
$4.44K Buy
10,400
+400
+4% +$174 ﹤0.01% 3374
2025
Q1
$4.07K Sell
10,000
-206
-2% -$132 ﹤0.01% 2969
2024
Q4
$6.76K Hold
10,206
﹤0.01% 2938
2024
Q3
$8.66K Hold
10,206
﹤0.01% 2730
2024
Q2
$6.81K Hold
10,206
﹤0.01% 2532
2024
Q1
$13.3K Hold
10,206
﹤0.01% 2397
2023
Q4
$5.85K Sell
10,206
-800
-7% -$553 ﹤0.01% 2301
2023
Q3
$8.3K Buy
+11,006
New +$8.37K ﹤0.01% 2221

Other funds holding VXRT

Wealth Enhancement Advisory Services's VXRT Position: Q4 2025 in Review

Wealth Enhancement Advisory Services sold out of Vaxart (VXRT) in Q4 2025, closing a stake of 10,400 shares — an estimated $3.65K sold.

Wealth Enhancement Advisory Services first reported a position in VXRT in Q3 2023 and held it in 9 quarters. The position peaked at $13.3K in Q1 2024. 5 funds tracked by Wall St. Rank hold VXRT as of Q4 2025.

  • Wealth Enhancement Advisory Services reported no remaining Vaxart position as of Q4 2025 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 10,400 Vaxart shares in Q4 2025, an estimated $3.65K.
  • Wealth Enhancement Advisory Services first reported a position in Vaxart in Q3 2023 and held it in 9 quarters.
  • Wealth Enhancement Advisory Services's Vaxart position peaked at $13.3K in Q1 2024.
  • 5 funds tracked by Wall St. Rank held Vaxart as of Q4 2025.

Based on Wealth Enhancement Advisory Services's 13F filing for Q4 2025, filed 8 Jan 2026.